Organ-specific Responses to Atezolizumab Plus Bevacizumab in Advanced HCC

Clinical trial NCT04862949 · COMPLETED

Trial details

NCT number: NCT04862949
Sponsor: CHA University
Status: COMPLETED
Study type: OBSERVATIONAL

Advanced Hepatocellular Carcinoma

Start date: 2021-05-01
Primary completion: 2022-12-31
Enrollment: 131

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.